Tumour necrosis factor-alpha as a tumour promoter

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Peter SzlosarekFrances R Balkwill

Abstract

It is becoming more evident that many aspects of tumour promotion arise from persistent and unresolving inflammation. One of the key molecules mediating the inflammatory processes in tumour promotion is the cytokine, tumour necrosis factor-alpha (TNF-alpha). Clinically, elevated serum concentrations and increased expression of TNF-alpha are present in various pre-neoplastic and malignant diseases, compared with serum and tissue from healthy individuals. Although over the last few decades high-dose administration of TNF-alpha has been used as a cytotoxic agent, recent pre-clinical cancer models have provided critical evidence to support the link between chronic, low level TNF-alpha exposure and the acquisition of pro-malignant phenotype (i.e., increased growth, invasion and metastasis). Furthermore, sophisticated cellular systems are being utilised to dissect the crucial role TNF-alpha plays in the communication of stromal/inflammatory cells and tumour cells. Understanding the intricate roles of TNF-alpha in the process of tumour promotion will assist in the development of novel cancer therapeutics.

References

Sep 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·E A CarswellB Williamson
Jan 1, 1990·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S T MalikF R Balkwill
Nov 15, 1989·International Journal of Cancer. Journal International Du Cancer·S T MalikF R Balkwill
Aug 1, 1994·International Journal of Cancer. Journal International Du Cancer·M MaedaY Niitsu
Jun 1, 1994·Critical Reviews in Oncology/hematology·C N Baxevanis, M Papamichail
May 1, 1993·The Journal of Experimental Medicine·P OroszD N Männel
Sep 22, 1998·British Journal of Cancer·T M Leber, F R Balkwill
Jul 30, 1999·Carcinogenesis·R A Roberts, I Kimber
Jan 6, 2000·The Journal of Experimental Medicine·H KörnerM J Smyth
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Mar 7, 2001·Lancet·F Balkwill, A Mantovani
Apr 27, 2001·Seminars in Cancer Biology·T D Tlsty
Mar 19, 2002·Cellular Signalling·David J MacEwan
Jun 1, 2002·Science·Guoqing Chen, David V Goeddel
Aug 31, 2002·Oncogene·Chris TselepisJanusz Antoni Z Jankowski
Dec 20, 2002·Nature·Lisa M Coussens, Zena Werb
Mar 26, 2003·Cell Death and Differentiation·H WajantP Scheurich
Jun 13, 2003·Molecular Biology of the Cell·Richard C Bates, Arthur M Mercurio
Sep 11, 2003·The Lancet Oncology·Peter W Szlosarek, Frances R Balkwill
Jan 2, 2004·European Journal of Cell Biology·Léon C L T van KempenLisa M Coussens
Feb 3, 2004·The Journal of Clinical Investigation·Anna ZganiaczZhou Xing
May 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·Tao LuAndrei V Gudkov
Aug 27, 2004·Nature·Eli PikarskyYinon Ben-Neriah
Sep 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Arno J MundtRalph R Weichselbaum

❮ Previous
Next ❯

Citations

May 21, 2013·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Hana Zelová, Jan Hošek
Jun 10, 2008·Analytical and Bioanalytical Chemistry·Gargi GhoshKimberly W Anderson
Sep 21, 2012·Seminars in Immunopathology·Takuji Tanaka, Hideki Ishikawa
Dec 11, 2007·Cancer Metastasis Reviews·David G DeNardoLisa M Coussens
Jan 9, 2008·Cancer Metastasis Reviews·Isaac P Witz
Feb 3, 2011·Cancer Metastasis Reviews·Khashayarsha KhazaieDavid J Bentrem
Apr 25, 2012·Cancer Metastasis Reviews·Katharine L SodekMaurice J Ringuette
Jun 16, 2012·Cancer Metastasis Reviews·Jonathan P Sleeman
Mar 12, 2009·Medical Oncology·Inès ZidiNidhal Ben Amor
Jul 28, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ines Zidi, Nidhal Ben Amor
Aug 15, 2008·Proceedings of the National Academy of Sciences of the United States of America·Toshimitsu YamaokaD Brent Polk
Mar 8, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E R BrownJ F Smyth
Jan 12, 2012·Carcinogenesis·Lori Hartnett, Laurence J Egan
Aug 6, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Brahim AissaniRichard A Kaslow
Oct 2, 2009·American Journal of Physiology. Cell Physiology·James YooEnrique Rozengurt
Jan 29, 2011·Journal of Biomedicine & Biotechnology·Manasa KannegantiEmiko Mizoguchi
May 3, 2008·Cancer Research·Stefan Fichtner-FeiglWarren Strober
Sep 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hua ZhongGalina V Shurin
Jul 21, 2010·The Journal of Clinical Investigation·Hongxia Z ImtiyazM Celeste Simon
May 9, 2012·The Journal of Clinical Investigation·Daofeng LiuLeonid S Metelitsa
Aug 30, 2007·Journal of Zhejiang University. Science. B·Zhi-qing Chen, Xiao-yun Fang
Jan 1, 2009·Folia Histochemica Et Cytobiologica·Bozena DobrzyckaLech Chyczewski
May 9, 2007·Frontiers in Bioscience : a Journal and Virtual Library·Paraic A KennyMina J Bissell
Jan 22, 2009·Journal of Nutritional Science and Vitaminology·Wataru KomatsuKazumi Yagasaki
Feb 9, 2012·International Journal of Molecular Sciences·Masahito ShimizuHisataka Moriwaki
Jul 19, 2013·International Journal of Molecular Sciences·Takahiro KochiHisataka Moriwaki
Dec 14, 2007·Proceedings of the National Academy of Sciences of the United States of America·Elias GounarisKhashayarsha Khazaie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Biochemical Pharmacology
Bharat B AggarwalGautam Sethi
Nature
Lisa M Coussens, Zena Werb
© 2021 Meta ULC. All rights reserved